Biotechnology - , ,
Atorvia is a pre-clinical stage biotech whose purpose is to transform acute care. With an initial focus on acute kidney injury (AKI), a devastating condition that affects millions worldwide yet lacks effective treatment, we are developing a kidney-targeted peptide with a novel mechanism of action that prevents regulated cell death and kidney failure.Adopting a commercialization mindset early in the development process, Atorvia works with world leading researchers and leading scientists to transform great science into approvable treatments that meet patient & physician need - and for which payors will pay.Headquartered in Canada with operations in Massachusetts, USA, Atorvia is curating a pipeline of acute care technologies that will disrupt the existing landscape and transform patient care.
Outlook
Varnish
Wix
Mobile Friendly
Google Cloud Hosting